Spinal muscular atrophy: a perspective outlook

Spinal muscular atrophy: a perspective outlook

Background. Recent decades have witnessed a leap in understanding the molecular genetic bases of spinal muscular atrophy for a considerable improvement in diagnosis and treatment of this disease and development of innovative therapies for correcting genetic deﬁciencies. Given scarcity of etiotropic...

Full description

Bibliographic Details
Main Authors:	M. R. Shaimurzin, I. S. Lutskiy
Format:	Article
Language:	Russian
Published:	Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2020-12-01
Series:	Кубанский научный медицинский вестник
Subjects:	spinal muscular atrophy rhs and mhs scales electromyography therapy
Online Access:	https://ksma.elpub.ru/jour/article/view/2288

Similar Items

Rehabilitation in spinal muscular atrophy
by: Joanna Iłżecka
Published: (2021-05-01)

Histone deacetylase inhibitors as potential treatment for spinal muscular atrophy
by: Jafar Mohseni, et al.
Published: (2013-01-01)

Alternative Splicing Role in New Therapies of Spinal Muscular Atrophy
by: Jan Lejman, et al.
Published: (2021-08-01)

Sensory changes in pediatric patients with spinal muscular atrophy: an electrophysiologic study
by: Hussien E Sultan, et al.
Published: (2016-01-01)

Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy
by: Katarzyna Kotulska, et al.
Published: (2021-10-01)

Spinal Muscular Atrophy With Myoclonic Epilepsy
by: Buket ÖZKARA, et al.
Published: (2017-04-01)

Oral risdiplam for specific therapy in adult patients with 5q spinal muscular atrophy in the Moscow region
by: Ekaterina S. Novikova
Published: (2023-09-01)

The social-economic burden of spinal muscular atrophy in Russia
by: A. S. Kolbin, et al.
Published: (2021-02-01)

Dificuldades diagnósticas na atrofia muscular espinhal Spinal muscular atrophy diagnostic difficulties
by: Alexandra Prufer de Q-C. Araújo, et al.
Published: (2005-03-01)

Survival analysis of spinal muscular atrophy type I
by: Hyun Bin Park, et al.
Published: (2010-11-01)

Research progress of spinal muscular atrophy treatment in children
by: Miao ZHAO, et al.
Published: (2018-04-01)

Rehabilitation in spinal muscular atrophy
by: Agus Iwan Foead, et al.
Published: (2019-01-01)

Spinal muscular atrophy and ependymoma
by: Aishah Albakr, et al.
Published: (2017-01-01)

Spinal adhesive arachnoiditis in an adult patient with spinal muscular atrophy type 3 treated with intrathecal therapy
by: Jakub Ubysz, et al.
Published: (2024-01-01)

First Use of Non-Invasive Spinal Cord Stimulation in Motor Rehabilitation of Children with Spinal Muscular Atrophy
by: Anton Novikov, et al.
Published: (2023-02-01)

Spinal muscular atrophy
by: D'Amico Adele, et al.
Published: (2011-11-01)

New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges
by: Sonia Messina, et al.
Published: (2020-07-01)

Growth patterns in children with spinal muscular atrophy
by: Ramona De Amicis, et al.
Published: (2021-09-01)

Clinical and biochemical polymorphism of spinal muscular atrophy
by: M. G. Sokolova, et al.
Published: (2017-03-01)

Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders
by: Sibylle Jablonka, et al.
Published: (2022-01-01)

Natural history of lung function in spinal muscular atrophy
by: Camiel A. Wijngaarde, et al.
Published: (2020-04-01)

Epidural anesthesia for the patient with type IV spinal muscular atrophy -A case report-
by: Seon Jin Kim, et al.
Published: (2010-12-01)

Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapiesResearch in context
by: Marika Pane, et al.
Published: (2023-05-01)

Association between spinal muscular atrophy type and delayed diagnosis and the risk of spinal deformity in Indonesian patients
by: Dian Marta Sari, et al.
Published: (2023-03-01)

A mixed method study on the impact of living with spinal muscular atrophy in Malaysia from patients’ and caregivers’ perspectives
by: Gaik Siew Ch’ng, et al.
Published: (2022-05-01)

Application of ICF classification system in functional assessment of children with spinal muscular atrophy
by: O.V. Nazar, et al.
Published: (2022-03-01)

Metabolic and Nutritional Issues Associated with Spinal Muscular Atrophy
by: Yang-Jean Li, et al.
Published: (2020-12-01)

Spinal Muscular Atrophy II/III and Feeding Problems
by: J Gordon Millichap
Published: (2012-03-01)

Very severe spinal muscular atrophy (Type 0)
by: Suleiman Al Dakhoul
Published: (2017-01-01)

Early Development of Spinal Deformities in Children Severely Affected with Spinal Muscular Atrophy after Gene Therapy with Onasemnogene Abeparvovec—Preliminary Results
by: Venla Soini, et al.
Published: (2023-06-01)

Experience and Perspectives in the US on the Evolving Treatment Landscape in Spinal Muscular Atrophy
by: Ramos-Platt L, et al.
Published: (2022-09-01)

Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States
by: Cathy Lally, et al.
Published: (2017-11-01)

Innovating spinal muscular atrophy models in the therapeutic era
by: Ilaria Signoria, et al.
Published: (2023-09-01)

Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening—A Systematic Review
by: Karolina Aragon-Gawinska, et al.
Published: (2023-06-01)

Perioperative rehabilitation management for a child with spinal muscular atrophy: one case report
by: LI Wen‑zhu, et al.
Published: (2023-09-01)

Clinical Practice Guideline for Adolescent & Adult Patients with Spinal Muscular Atrophy
by: Rare Disease Society of Chinese Research Hospital Association, et al.
Published: (2023-01-01)

Clinical Practice Guideline for Adolescent & Adult Patients with Spinal Muscular Atrophy
by: Rare Disease Society of Chinese Research Hospital Association, et al.
Published: (2023-04-01)

Clinical Practice Guideline for Adolescent & Adult Patients with Spinal Muscular Atrophy
by: Rare Disease Society of Chinese Research Hospital Association, et al.
Published: (2023-07-01)

Changes in electrophysiological findings of spinal muscular atrophy type I after the administration of nusinersen and onasemnogene abeparvovec: two case reports
by: Tomoko Mizuno, et al.
Published: (2023-10-01)

Molecular And Epidemiological Characterization Of SMN Genes In Cuban Patients With Spinal Muscular Atrophy
by: Fabián Lombillo, et al.
Published: (2019-05-01)